Proto Labs, Inc.
NYSE:PRLBManufacturing - Miscellaneous
+$1.44 today
- Market cap
- $1.53B
- Beta
- 1.39
- P/E (TTM)
- 75.0
- EPS (TTM)
- $1.08
Volume 0.23M
Average 0.18M
PRLB Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Proto Labs, Inc.NYSE: PRLB
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents rises 41.5% from a year ago
Cash & equivalents stood at $127.92M at the end of Q2 FY2026, up 41.5% from a year earlier and up 3.2% from the prior quarter. Over 3 fiscal years it compounded at +25.1% a year.
Context
- Cash & equivalents amounted to 16.2% of total assets at the end of Q2 FY2026, up 4.0 pp from a year earlier.
- Cash & equivalents increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +41.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 110.83M USD
- Year-over-year change
- +24.4%
- 4-year CAGR
- +13.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 110.83M | +24.4% |
| FY2024 | 2024-12-31 | 89.07M | +6.3% |
| FY2023 | 2023-12-31 | 83.79M | +48.1% |
| FY2022 | 2022-12-31 | 56.56M | -14.2% |
| FY2021 | 2021-12-31 | 65.93M | — |
Cash & Equivalents vs competitors
How PRLB compares with its peers on the latest reported figures
- PRLB's Jun 2026 cash & equivalents of $127.92M is the 4th highest of the 10 companies compared; the peer median is $113.1M.
- Its year-over-year change of +41.5% is the 4th highest of 9, against a peer median of +17.6%.
- Cash & equivalents amounts to 16.2% of total assets for PRLB, versus a peer median of 7.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Feb 2026 | $521.8M | +72.8% | -16.4% | 12.0% | |
CCECCapital Clean Energy Carriers Corp. | Sep 2025 | $310.74M | — | — | 7.5% |
| Feb 2026 | $186.11M | +8.2% | +33.6% | 22.2% | |
| Jun 2026 | $127.92M | +41.5% | +25.1% | 16.2% | |
EVEXEve Holding, Inc. | Mar 2026 | $120.94M | +103.2% | +28.1% | 25.0% |
RHLDResolute Holdings Management, Inc. | Mar 2026 | $113.1M | +59.3% | +169.3% | 1.8% |
| Apr 2026 | $112M | -20.5% | +35.4% | 8.6% | |
| Apr 2026 | $32.5M | +26.9% | -16.6% | 4.9% | |
| Mar 2026 | $10.1M | -92.9% | +54.8% | 0.3% | |
| Sep 2026 | $14.56K | -99.9% | -24.1% | 0.4% | |
| Peer median (excluding PRLB) | $113.1M | +17.6% | +30.8% | 7.5% | |
Competitors are the stored peer set for PRLB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 65.93M | 56.56M | 83.79M | 89.07M | 110.83M |
| Short-term Investments | 11.58M | 23.57M | 19.01M | 14.02M | 17.3M |
| Net Receivables | 81.37M | 80.27M | 75.08M | 69.41M | 81.43M |
| Inventory | 13.16M | 13.58M | 13.66M | 12.31M | 14.4M |
| Other Current Assets | 0 | 12.6M | 9.12M | 10.05M | 9.59M |
| Total Current Assets | 183.49M | 186.57M | 200.66M | 194.85M | 233.54M |
| Property, Plant & Equipment (Net) | 287.82M | 279.16M | 259.24M | 230.95M | 218.52M |
| Goodwill | 400.61M | 273.99M | 273.99M | 273.99M | 273.99M |
| Intangible Assets | 38M | 31.25M | 25.58M | 21.42M | 18.61M |
| Long-term Investments | 14.34M | 26.42M | 8.02M | 17.77M | 14.31M |
| Tax Assets | 0 | 0 | 0 | 0 | 20.3M |
| Other Non-current Assets | 4.32M | 4.78M | 4.86M | 4.52M | 4.44M |
| Total Non-current Assets | 745.09M | 615.6M | 571.69M | 548.66M | 550.17M |
| Total Assets | 928.58M | 802.17M | 772.35M | 743.51M | 783.71M |
| Account Payables | 25.36M | 17.36M | 15.64M | 15.5M | 15.1M |
| Short-term Debt | 0 | 0 | 0 | 0 | 1.44M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 9.6M |
| Other Current Liabilities | 13.7M | 12.74M | 15.29M | 16.55M | 17.18M |
| Total Current Liabilities | 54.9M | 71.58M | 49.68M | 53.27M | 67M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 35.89M | 26.32M | 18.74M | 13.57M | 36.89M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 5.71M | 4.36M | 5.03M | 4.61M | 4.28M |
| Total Non-current Liabilities | 45.19M | 32.94M | 27.38M | 20.09M | 42.78M |
| Total Liabilities | 100.09M | 104.52M | 77.06M | 73.36M | 109.78M |
| Common Stock | 28K | 27K | 26K | 24K | 24K |
| Retained Earnings | 376.73M | 258.24M | 256.4M | 244.41M | 240.76M |
| Accumulated OCI | (16.82M) | (34.36M) | (28.01M) | (27.98M) | (20.98M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 828.49M | 697.65M | 695.3M | 670.15M | 673.93M |
| Total Debt | 7.44M | 21.35M | 5.48M | 3.52M | 3.05M |
| Net Debt | (58.49M) | (35.21M) | (78.31M) | (85.56M) | (107.78M) |
Proto Labs, Inc.
NYSE:PRLB
Intrinsic Alpha fair value
Locked
Current Price
$63.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.